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Differentiation-stimulating factor (D-factor)/leukemia inhibitory factor is a cytokine inducing differentiation of mouse myeloid leukemic MI-T22 
cells. The effect of recombinant human D-factor on growth and differentiation of pig kidney LLC-PK, cells was examined. LLC-PK, cells did 
not concentrate a-methylglucoside during their early growth in culture but developed the capacity to concentrate this hexose as they reached con- 
fluence and their growth rate decreased. Purified D-factor caused dose-dependent inhibition of the development of this concentrative capacity. It 
did not affect the growth rate of the cells, but inhibited the formation of multicellular domes in confluent cultures. LLC-PK, cells were found 
to have high-affinity binding sites (831 per cell) for D-factor with a dissociation constant of 197 pM. 
Pig kidney cell; Sugar transport; Differentiation-stimulating factor; Leukemia inhibitory factor; Differentiation-inhibiting activity 
1. INTRODUCTION 
Previously, we purified a cytokine inducing differen- 
tiation of mouse myeloid leukemic Ml-T22 cells into 
macrophages [1,2] and designated this cytokine as D- 
factor. We also characterized D-factor receptors on Ml 
cells [3] and isolated complementary DNA encoding 
human D-factor [4]. Metcalf and coworker also 
purified the same cytokine [5], isolated complementary 
DNA for the cytokine [6] and named the cytokine 
leukemia inhibitory factor (LIF). D-factor/LIF was 
found to be identical to human interleukin that sup- 
ported proliferation of murine leukemia DA-la cells [7] 
and differentiation inhibiting activity that inhibited dif- 
ferentiation of pluripotent mouse embryo& stem cell 
lines [8,9]. In addition, D-factor/LIF stimulated bone- 
resorbing activity in mouse fetal calvaria [lo], synthesis 
of acute phase plasma proteins in hepatoma cells [ 1 l] 
and differentiation of rat sympathetic neurons [12]. 
Thus D-factor, like interleukin 6, affects the growth 
and differentiation of a wide variety of cells. We screen- 
ed various cell lines for D-factor receptors, and found 
that some kidney cell lines have relatively higher 
numbers of D-factor receptors. In the present work, we 
examined the effects of D-factor on the growth and dif- 
ferentiation of LLC-PKr cells, a dome-forming cell line 
derived from juvenile pig kidney [13]. The dome is a 
fluid-filled hemicyst and is considered to be, at least in 
part, a manifestation of transepithelial ion and water 
transport [14]. In addition, LLC-PKr cells show 
Na + -dependent hexose transport activity [ 15- 181. This 
activity is normally found only in terminally differen- 
tiated epithelia such as those of the kidney and in- 
testine. 
2. MATERIALS AND METHODS 
2.1. Cells and cell culture 
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The pig kidney epithelial cell line LLC-PKI (ATCC CRL1392) was 
obtained from Flow Laboratories (Tokyo, Japan) at passage 190, and 
cultured in a 50:50 mixture of Dulbecco’s modified Eagle’s medium 
and Ham’s F12 (Flow Laboratories) supplemented with 10% fetal 
calf serum (Gibco, Grand Island, NY) and 100 W/ml of streptomycin 
in an atmosphere of 5% CO2 in air at 37°C. Cells in confluent 
monolayers were separated with 0.25% trypsin and 0.02% EDTA and 
subcultured at a split ratio 1: 10. Cultures reached confluence on day 
3-4 after subculture. 
2.2. Sugar uptake 
Abbreviations: D-factor, differentiation-stimulating factor; LIF, Sugar uptake was measured by the method of Amsler and Cook 
leukemia inhibitory factor; a-meG, methyl cr-D-glucopyranoside; [15]. The cells were plated in Costar 6-well dishes (35 mm diameter), 
CAMP, adenosine 3’ ,5’-cyclic monophosphate; HBSS, Hank’s at 1.5 x 16 cells per well, and the medium was changed every 2 days. 
balanced salt solution; Hepes, 4-(2-hydroxyethyl)-l-piperazine- D-Factor was added at the time of the first medium change 2 days 
ethanesulfonic acid after plating. For assay of uptake, the medium was poured off, and 
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the monolayers were rinsed twice with 2 ml of Hank’s balanced salt 
solution (HBSS) buffered at pH 7.3 with 10 mM 4-(2_hydroxyethyl)- 
I-piperazine-ethanesulfonic a id (Hepes). The uptake assay was in- 
itiated by addition of 1 ml of HBSS containing [‘4C]methyl-cr-D- 
glucopyranoside (cr-meG, Amersham) at a final concentration of 100 
FM and 0.2 &i/ml. After incubation at 37°C for 60 min, the medium 
was removed, and the monolayers were washed three times with 2 ml 
of ice-cold HBSS. Then they were solubilized in 1 ml of 1% sodium 
dodecyl sulfate, and radioactivity was measured using ACS III 
(Amersham) as scintillation liquid. For determination of cell protein, 
the monolayers were solubilized in 0.25 N NaOH, and protein was 
determined by the dye fixation method (Bio-Rad Laboratories) with 
bovine serum albumin as a standard. 
2.3. D-factor 
D-factor was purified to homogeneity from conditioned medium of 
CHO cells transfected with the plasmid containing cDNA encoding 
human D-factor [4]. Recombinant human D-factor and native mouse 
D-factor induced differentiation of Ml-T22 cells at similar concentra- 
tions. Purified recombinant human D-factor (0.5 ng/ml) induced 
50% phagocytic cells in Ml-T22 cell cultures. 
2.4. Cellular binding of L2sI-D-factor 
D-factor was iodinated with chloramine-T in the presence of 12.5% 
dimethyl sulfoxide as described previously [3]. The specific radioac- 
tivity of the ‘251-D-factor preparation was 1.6x lo5 cpm/ng protein. 
For assay of binding of ‘251-D-factor, LLC-PKr cells were plated in 
12-well plates. The confluent cells (8.88~ lO’/well) obtained by 
culture for 3 days were washed twice with phosphate-buffered saline 
and incubated in 1 ml of culture medium containing *251-D-factor and 
25 mM Hepes with or without 30-fold excess of unlabelled D-factor 
for 3 h at 21°C as described [3]. After incubation, the medium was 
removed and the cells were washed three times with cold phosphate- 
buffered saline. Then they were solubilized in 1 ml of 1 N NaOH, and 
their radioactivity was measured in a gamma-counter. Specific 
binding was determined by subtracting the binding in the presence of 
30-fold excess of unlabelled D-factor. 
2.5. Enzyme activities 
Cultures were rinsed 3 times with ice-cold 0.9% NaCl. Cells were 
harvested in 1 ml of 0.25 M sucrose with a rubber policeman and 
sonicated in an ice-bath by 3 x 15 s bursts at intervals 30 s. Alkaline 
phosphatase (EC 3.1.3.1) was determined by a reported method [19]. 
The reaction mixture (0.5 ml) contained 8 mM pnitrophenylphos- 
phate, 0.5 M 2-amino-2-methyl-1-propanol (pH 10.3) and 25 ~1 of cell 
lysate. After incubation at 37°C for 10 min, the reaction was stopped 
with 1.5 ml of 0.25 N NaOH. The absorbance of the samples at 410 
nm was compared with that of a standard solution of p-nitrophenol. 
y-Glutamyl transpeptidase (EC 2.3.2.2) was determined as in [18]. 
The reaction mixture (1 ml) contained 2.2 mM y-glutamyl-p- 
nitroanilide, 20 mM glycylglycine, 0.1 M Tris-HCl, pH 8.2, and 100 
pl of cell lysate. After incubation at 37°C for 10 min, the reaction was 
stopped with 2 ml of 10% acetic acid. The absorbance of the samples 
at 410 nm was compared with that of a standard solution of p- 
nitroaniline. Enzyme activities are expressed in pmol.mg pro- 
tein-‘.h-‘. 
3. RESULTS 
3. I. Binding of ‘251-D-factor to LLC-PKI cells 
We examined the bindings of ‘251-D-factor to various 
kidney cell lines. “‘I-D-factor bound to only 2 of the 8 
cell lines tested. These two cell lines did not produce D- 
factor, whereas the other 6 cell lines produced signifi- 
cant amounts of D-factor. Thus even if the cells did not 
bind i2?-D-factor, they might have receptors, because 
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Fig. 1. Binding of ‘251-D-factor to LLC-PKr cells. (A) Specific bin- 
ding was determined by subtracting the binding in the presence of 
30-fold excess of unlabelled D-factor. Points and bars are means + 
SE for duplicate determinations. (B) Data plotted by Scatchard’s 
method. B = bound r2’I-D-factor concentration. 
autocrine D-factor might block the binding of ii?-D- 
factor added exogenously. 
We analyzed the binding of D-factor to LLC-PKi 
cells as described previously [3]. Scatchard analysis 
revealed that the cells expressed 831 high affinity D- 
factor receptors per cell with an apparent dissociation 
constant of approximately 197 pM (Fig. 1). 
3.2. Inhibition of development of Na ’ -dependent 
hexose transport by D-factor 
We examined the effects of D-factor on growth and 
differentiation of LLC-PKi cells. D-factor did not in- 
hibit growth of the cells inoculated at low density, and 
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Fig. 2. Effects of D-factor on development of activity for uptake of 
cy-methylglucoside (A) and on growth of the cells (B). Cells were in- 
cubated with (0) or without (0) 20 ng/ml of D-factor from 2 days after 
plating. Values are means for duplicate determinations. 
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Fig. 3. Inhibition by D-factor of development of activity for uptake 
of o-methylglucoside. Cells were treated with various amounts of D- 
factor from 2 days after plating, and sugar uptake was determined 
after treatment with D-factor for 5 days. Points and bars are means 
+ SE for duplicate determinations. 
did not stimulate growth of cells inoculated into 
medium without serum. However, the saturation densi- 
ty of the cells treated with D-factor was slightly lower 
than that of untreated cells (Fig. 2B). Moreover, 
although cells treated with D-factor formed confluent 
monolayers, their formation of multicellul~ domes was 
suppressed. In control cultures, domes appeared on day 
3 (5 days after plating), and on day 5 there were 97 
domes/cm2: 65 small domes and 32 large domes. On the 
other hand, in cultures treated with D-factor, there 
were only small domes (29 domes/cm’). In addition, a 
few round cells were released into the medium from 
confluent monolayer treated with D-factor, and 
although the medium was changed every 2 days, it 
became more acidic than that of control cultures. 
In control cultures Na + -dependent a-methyl- 
glucoside transport started on day 4 (Fig. 2A). D-factor 
inhibited its appearance, causing appreciable inhibi- 
tion at concentrations of more than 0.5 ng/ml and 
maximum inhibition at concentrations of more than ’ 
10 ng/ml (Fig. 3). 
Next, we assayed the activities of the apical marker 
enzymes, alkaline phosphat~e and ~-glut~yl 
transpeptidase [19]. The activities of these enzymes 
were low in sparse cultures, but increased after the cells 
reached a con~uent density (Table I). D-Factor did not 
inhibit increase in these enzyme activities, and slightly 
stimulated increase in alkaline phosphatase. 
4. DISCUSSION 
At confluence, LLC-PKi cells simultaneously 
develop the differentiated properties of apical 
Na + -hexose cotransport, apical marker enzyme ac- 
tivities and transepithelial fluid transport. In this work, 
we showed that recombinant human D-factor inhibited 
development of Na+-dependent hexose transport in pig 
kidney cells. It also inhibited dome formation, but did 
not inhibit increase in the activities of alkaline 
phosphatase and y-glutamyl transpeptidase. Van Den 
Bosh et al, [17] isolated several subclones which dif- 
fered with respect to development of Na+ -dependent 
hexose uptake from LLC-PKi cells and showed that the 
expressions of Na + -dependent hexose transport and the 
activities of alkaline phosphatase and y-glutamyl 
transpeptidase were not correlated. These results sug- 
gest that the expressions of several differentiated 
characteristics are regulated independently. Na+ - 
dependent hexose transport activity is a typical char- 
acteristic of renal proximal tubules. Its expression is in- 
fluenced by the time after confluency and by the D- 
glucose concentration in the growth medium [16]. The 
Friend cell inducer hexamethylene bisacetamide and 
phosphodiesterase inhibitors, including dibutyryl 
CAMP, theophylline and l-methyl-3-isobutylxanthine, 
accelerated the development of hexose concentrating 
capacity [15]. On the other hand, the tumor promotor 
12-0-tetradecanoylphorbol-13-acetate inhibited the 
development of the concentrative capacity. The CAMP 
levels in the cells were determined, but were found not 
to explain the mech~ism of inhibition of 12-O-tetra- 
decanoyl phorbol-13-acetate. [ 151. 
Various cytokines that affect the growth and dif- 
ferentiation of myeloid cells and lymphocytes have been 
identified recently. Many of these cytokines were found 
to be active on a wide variety of other cells besides the 
blood cells. However, the effects of these cytokines on 
the differentiation of LLC-PKr cells have not yet been 
examined. To our knowledge, this is the first report that 
Table I 
Effects of D-factor on inductions of marker enzymes in LLC-PKt cells 
Cells Alkaline phosphatase r-Glutamyl transoentidase 
Day D-factor 
&mol.mg-‘.h-‘) 
- . 
@mol.mg-*h-l) 
1 - 11.0 f 0.2b 9.6 f 0.2 
5 - 53.2 f 2.8 42.2 & 3.5 
5 += 70.9 f 4.3 44.1 rf 2.3 
a Ceils (3 x Id) were incubated into 60 mm dishes. D-factor (20 ng/ml was added at the 
time of the first medium change 2 days after plating, and the cells were harvested after 
treatment with D-factor for 5 days 
b Mean + SE of determinations in 4 dishes. 
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a well characterized cytokine, D-factor, inhibits the 
development of Na + -dependent hexose transport in 
these cells. 
We found that LLC-PKr cells have specific receptors 
for D-factor and that the affinity and number of these 
receptors are similar to those on myeloid leukemic Ml 
cells [3] and mouse embryonal stem cells [8,9]. The 
structure of the D-factor receptor and mechanism of ac- 
tion of D-factor on these cells remain to be examined. 
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